BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34157940)

  • 1. Constructing a new prognostic signature of gastric cancer based on multiple data sets.
    Zhou L; Lu H; Zeng F; Zhou Q; Li S; Wu Y; Yuan Y; Xin L
    Bioengineered; 2021 Dec; 12(1):2820-2835. PubMed ID: 34157940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
    Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
    Front Immunol; 2021; 12():719628. PubMed ID: 34413861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.
    Zhang F; Maswikiti EP; Wei Y; Wu W; Li Y
    Dis Markers; 2021; 2021():5567392. PubMed ID: 34422135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
    Zhu M; Cai J; Wu Y; Wu X; Feng L; Yin Z
    Med Sci Monit; 2021 Jan; 27():e928195. PubMed ID: 33471782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
    Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
    Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new RNA-binding proteins-based signature for prognostic prediction in gastric cancer.
    Wang Y; Ye W; Tian G; Zhang Y
    Medicine (Baltimore); 2022 Feb; 101(8):e28901. PubMed ID: 35212295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.
    Zhou L; Li SH; Wu Y; Xin L
    Cancer Med; 2021 May; 10(10):3309-3322. PubMed ID: 33934516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
    Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
    J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism-related eight-gene signature can predict the prognosis of gastric adenocarcinoma.
    Yin HM; He Q; Chen J; Li Z; Yang W; Hu X
    J Clin Lab Anal; 2021 Dec; 35(12):e24085. PubMed ID: 34773716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.